CHERYL CAMPBELL: Open Payments
NPI 1437393717 · WINTER HAVEN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$499 in 23 payments from 13 companies in 2025. Trend: 2023 $454 · 2024 $839 · 2025 $499
Food & beverage: $456Education: $43
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 2 | $107 |
| Organon LLC | 7 | $59 |
| ABBVIE INC. | 3 | $47 |
| Lilly USA, LLC | 1 | $46 |
| Janssen Biotech, Inc. | 1 | $43 |
| PFIZER INC. | 2 | $42 |
| Galderma Laboratories, L.P. | 1 | $37 |
| Kerecis Limited | 1 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
Products named: DUPIXENT, SKYRIZI, EBGLYSS, TREMFYA, CIBINQO, NEMLUVIO, Kerecis SurgiClose, VTAMA.
Industry payments across FL — which companies pay providers there.
